Paroxetine with pindolol augmentation: A double-blind, randomized, placebo-controlled study in depressed in-patients
- 29 February 2008
- journal article
- clinical trial
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 18 (2), 141-146
- https://doi.org/10.1016/j.euroneuro.2007.09.002
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pindolol is a potent scavenger of reactive nitrogen speciesLife Sciences, 2005
- Pindolol Augmentation in Depressed Patients Resistant to Selective Serotonin Reuptake InhibitorsBritish Journal of Psychology, 2004
- Differential Occupancy of Somatodendritic and Postsynaptic 5HT1A Receptors by Pindolol A Dose-Occupancy Study with [11C]WAY 100635 and Positron Emission Tomography in HumansNeuropsychopharmacology, 2001
- Augmentation of Fluoxetine's Antidepressant Action by Pindolol: Analysis of Clinical, Pharmacokinetic, and Methodologic FactorsJournal of Clinical Psychopharmacology, 2001
- Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonistsTrends in Neurosciences, 1996
- Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)International Clinical Psychopharmacology, 1994
- Time course of improvement under antidepressant treatment: A survival-analytical approachEuropean Neuropsychopharmacology, 1993
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960